News

  1. Home
  2. News

Check out our new article: ‘Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights’ – OPEN ACCESS

López-Estévez, A.M., Zhang, Y., Medel, M. et al. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights. Nano Res. (2024). https://doi.org/10.1007/s12274-024-6826-8

For those of you interested in doing a PhD in Nanomedicine: second call open for the IMDEA Nanociencia Doctoral Training Programme

IDEAL PhD is the IMDEA Nanociencia PhD Programme co-funded by the Horizon Europe Marie Skłodowska-Curie Actions COFUND programme. IDEAL PhD second call will attract 6 pre-doctoral researchers to carry out their thesis projects in one of the research areas developed at the Institute. The second call for IDEAL PhD closes on 23rd August, 2024.

Check out our new article: ‘Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines’ – OPEN ACCESS

Borrajo, M.L., Lou, G., Anthiya, S. et al. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01635-5

Check out our new OPEN ACCESS publication: ‘Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium’

Marcos-Villar, L., Perdiguero, B., Anthiya, S. et al. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium. npj Vaccines 9, 53 (2024). https://doi.org/10.1038/s41541-024-00838-8.

Grand Challenges in Global Health Annual Meeting 2023

Outstanding Grand Challenges Annual Meeting 2023, hosted by the Bill & Melinda Gates Foundation in Dakar

Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV)

Expediente: IN852 2021/16 Título: Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV) Miembros del Consorcio: Smart Vitamins, Universidad de Santiago de Compostela (USC), Fundación Instituto de Investigación Sanitario de Santiago de Compostela (FIDIS)

María José Alonso’s Lab participates in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines

María José Alonso’s and Noemi Csaba’s research groups at the Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) of the University of Santiago de Compostela (USC) will participate in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines.

Check out our new OPEN ACCESS publication: ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’

Shubaash Anthiya, Süleyman Can Öztürk, Hamdullah Yanik, Ece Tavukcuoglu, Adem Şahin, Dhrubajyoti Datta, Klaus Charisse, David Moreira Álvarez, María Isabel Loza, Alfonso Calvo, Einar Sulheim, Simon Loevenich, Geir Klinkenberg, Ruth Schmid, Muthiah Manoharan, Güneş Esendağlı, Maria Jose Alonso, 'Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors', Journal of Controlled Release.

MJ Alonso’s Lab Mini-Congress 2022

The Alonso’s Lab mini-congress is an annual event aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work.

MJ Alonso’s Lab wishes you a happy New Year!

Happy New Year to everyone! We wish you a fabulous 2023, full of great experiences and achievements in science.